Summary & Overview
HCPCS A7049: Expiratory Positive Airway Pressure Intranasal Valve
HCPCS Level II code A7049 denotes an expiratory positive airway pressure intranasal resistance valve, a durable medical device used to provide expiratory positive airway pressure via the nasal passages to support airway patency and noninvasive respiratory care. Nationally, device-level HCPCS codes like A7049 matter for DME coverage, billing consistency, and patient access to noninvasive respiratory aids.
Key payers included in the discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines what payers commonly consider for coverage determinations and claims processing for devices billed under HCPCS Level II codes.
Readers will find a concise overview of the clinical context for use of this valve, typical sites of service (outpatient ambulatory settings and home respiratory therapy), and the types of benchmarks and policy updates that commonly affect device reimbursement. The report highlights common modifier usage and payer-specific billing considerations when available. Where specific data elements are not provided in the input, the publication notes that those data are not available and focuses on general coding and clinical interpretation relevant to national audiences.
Billing Code Overview
HCPCS Level II code A7049 describes an expiratory positive airway pressure intranasal resistance valve. This device is used to provide expiratory positive airway pressure through the nasal passages to assist with airway patency and breathing support.
-
Service type: Durable medical device / respiratory assist device
-
Typical site of service: Durable medical equipment use in outpatient settings, home respiratory therapy, or other ambulatory care locations where noninvasive airway support is provided.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with obstructive sleep-disordered breathing or mild-to-moderate nasal valve collapse who experiences expiratory nasal airway resistance contributing to symptoms such as snoring, dyspnea on exertion, or poor tolerance of positive airway pressure therapy. The clinician (an otolaryngologist, sleep medicine physician, or pulmonologist) evaluates the patient in an outpatient clinic with history, focused nasal and nasopharyngeal exam, and objective testing as needed (e.g., nasal endoscopy or acoustic rhinometry). When conservative measures (topical nasal steroids, saline irrigation, external nasal dilators) are insufficient and the clinician determines that targeted intranasal expiratory positive airway pressure therapy may reduce expiratory nasal resistance, the provider fits or prescribes an intranasal resistance valve device described by A7049.
The clinical workflow includes patient selection, device sizing and fitting in clinic, instruction in use and cleaning, documentation of medical necessity in the medical record (symptoms, prior therapies, exam findings), and dispensing the device from clinic inventory or ordering through durable medical equipment. Follow-up visits assess symptom response, adherence, and need for alternative therapy. Billing uses HCPCS Level II code A7049 for the intranasal expiratory positive airway pressure resistance valve, with appropriate modifier(s) applied per payer and circumstance and an associated diagnosis code that justifies medical necessity in the claim.
Coding Specifications
| Modifier | Description | When to Use |
|---|